1. ESRC Genomics Network (archive)
  2. Gengage
  3. The Human Genre Project

Cesagen · People

Dr. Jane Miller

Cesagen Research Fellow

Qualifications

PhD

Telephone

02920 870544

Email

MillerJ4@cardiff.ac.uk

Building

10 Museum Place

Biography

Jane completed her PhD entitled “Health & the Human Genome Project: an analysis of the health impacts of genetic technologies using a broad model of health” in 2011. The study assessed the impact of some of the reported uses of technologies arising from the Human Genome Project. These were analysed through the use of the moral theory of Alan Gewirth and in light of the endorsed model of health. The abstract of the PhD can be read below:

The Human Genome Project (HGP) was an international scientific project that was launched in 1990 and its completion announced in 2003. The rationale behind it was that it would improve global health for the better and it was accompanied by many claims that were made about its positive impact upon health. These claims were made by scientists, doctors, politicians and legislators alike. An analysis of the global impact on health stemming from the HGP is far beyond the scope of this thesis, but in order to gauge the actualities of its effect on health thus far, it will assess the impact of some of the reported uses of technologies arising from the project. These will be analysed through the use of the moral theory of Alan Gewirth and in light of the endorsed model of health. Such an analysis will give a picture of the impact in terms of health of the HGP and its resultant technologies and whether these have been overwhelmingly positive or whether any negative impacts have arisen. As a result of such an analysis it is hoped that any common features of the use of these technologies can be seen, whether they be negative or positive, and hence whether any trends can be identified that may be useful in informing future use of these technologies in such a way that would promote beneficial outcomes and minimise any harms that could possibly arise. Although this is not an assessment of the whole picture of global health improvements that were claimed by the HGP, it will give an indication of the wider, global picture of the outcomes that may arise from the use of genetic technologies.